| Dr Melike Pekmezci, MD | |
|
2160 S 1st Ave, Building 101 Room 1739, Maywood, IL 60153-3328 | |
| (708) 327-4463 | |
| (708) 216-9033 |
| Full Name | Dr Melike Pekmezci |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 20 Years |
| Location | 2160 S 1st Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164746889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | A123227 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of California San Francisco | 4486567229 | 1298 |
News Archive
Difficulty breathing is the most common symptom before cardiac arrest, according to research presented at ESC Congress 2021.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A new blood test which has been developed by scientists in California may enable doctors to predict just who is likely to develop the the degenerative brain disease Alzheimer's.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.
› Verified 8 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
Difficulty breathing is the most common symptom before cardiac arrest, according to research presented at ESC Congress 2021.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A new blood test which has been developed by scientists in California may enable doctors to predict just who is likely to develop the the degenerative brain disease Alzheimer's.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.
› Verified 8 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
Difficulty breathing is the most common symptom before cardiac arrest, according to research presented at ESC Congress 2021.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A new blood test which has been developed by scientists in California may enable doctors to predict just who is likely to develop the the degenerative brain disease Alzheimer's.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melike Pekmezci, MD 2160 S 1st Ave, Building 101 Room 1739, Maywood, IL 60153-3328 Ph: (708) 327-4463 | Dr Melike Pekmezci, MD 2160 S 1st Ave, Building 101 Room 1739, Maywood, IL 60153-3328 Ph: (708) 327-4463 |
News Archive
Difficulty breathing is the most common symptom before cardiac arrest, according to research presented at ESC Congress 2021.
One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It's a serious problem and current diagnostic tests aren't very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
A new blood test which has been developed by scientists in California may enable doctors to predict just who is likely to develop the the degenerative brain disease Alzheimer's.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.
› Verified 8 days ago
Jason Kang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-327-2574 | |
Xianzhong Ding, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 847-687-6068 | |
Dr. Jodi J Speiser, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Department Of Pathology, Maywood, IL 60153 Phone: 414-688-7492 | |
Lifang Liu, Pathology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 513-584-3844 | |
Silver Daniel, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Building 101, Room 1739, Maywood, IL 60153 Phone: 708-216-9000 | |
Cagatay H Ersahin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, Ems Bldg., Rm. 2209, Maywood, IL 60153 Phone: 708-216-3250 Fax: 708-216-2620 | |
Dr. Brandon Zelman, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-327-2689 |